Genetic variations in TRAF1 have been linked to an increased risk of RA, and experimental disruption of TRAF1/cIAP2 interactions has been shown to attenuate inflammation and disease severity in arthritis models [26]. The gene discussed is BIRC3; the disease is rheumatoid arthritis.